Image pharmaphorum Editor Partner Content Partner Content AXON marks its spot…with more than an X AXON today launched a new brand visual identity to showcase its single-minded commitment to being ‘at the forefront of l R&D Importance of diversity in pharma and clinical trials “Diversity.” It’s a word that is very commonly thrown around right now, not just in pharma and healthcare but across all industries. Market Access How does rare disease prevalence impact drug pricing in Engl... In this second article of a three-part series exploring pricing in Europe, CRA’s Life Sciences Practice team discusses the role that disease rarity plays in reimbursement decisions among pa News Can synthetic control arms and real-world data offer a new w... Load more results
Partner Content Partner Content AXON marks its spot…with more than an X AXON today launched a new brand visual identity to showcase its single-minded commitment to being ‘at the forefront of l
R&D Importance of diversity in pharma and clinical trials “Diversity.” It’s a word that is very commonly thrown around right now, not just in pharma and healthcare but across all industries.
Market Access How does rare disease prevalence impact drug pricing in Engl... In this second article of a three-part series exploring pricing in Europe, CRA’s Life Sciences Practice team discusses the role that disease rarity plays in reimbursement decisions among pa
News UK modernises gene therapy definition in regulatory revamp The UK is planning changes to the definition of gene therapies and other genetic medicines, moving to a mechanism-based approach aligned with the EU.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.